Blood, Vol. 89 No. 5 (March 1), 1997:
pp. 1837b-1838
CORRESPONDENCE
Lack of Evidence of HHV-8 DNA in Blood Cells From Heart Transplant Recipients
 |
LETTER |
To the Editor:
The human herpesvirus type 8 (HHV-8), previously named as Kaposi's sarcoma-associated herpesvirus (KSHV),1 has been suggested to play a major role in the etiology and the pathogenesis of acquired immunodeficiency syndrome (AIDS)-associated and iatrogenic Kaposi's sarcoma (KS). In addition, evidence for HHV-8 involvement in primary effusion and possibly other human B-cell lymphomas has been recently provided.2 Although a role for HHV-8 in the pathogenesis of the above neoplasms is presently accepted by most investigators, controversial results have been obtained in molecular epidemiology studies with regard to the distribution of the virus in the healthy population. Two recent reports have shown detection of HHV-8 DNA sequences in semen from the vast majority of healthy adults3 and in peripheral blood mononuclear cells (PBMC) from ~10% of healthy subjects,4 suggesting that HHV-8 is a fairly common virus latently infecting humans. Thus, the involvement of HHV-8 in KS lesions1 and in non-KS skin lesions from immunosuppressed transplant recipients5 raises the possibility that the virus can reactivate in the presence of various immunosuppression conditions. By contrast, other investigators have failed to identify HHV-8 DNA in non-KS skin lesions from immunosuppressed transplant patients6 and in PBMC from a healthy adult population.7,8
We looked for the presence of HHV-8 DNA in 54 buffy-coat samples from 28 KS-negative immunosuppressed heart transplant recipients and 134 control buffy-coat samples from healthy blood donors. Periodical shell-vial culturing of oropharyngeal washing showed reactivation of cytomegalovirus (CMV), and/or herpes simplex virus 1 (HSV-1) in 18 of the 28 (64.3%) transplant patients during immunosuppressive treatment. DNA from buffy-coat cells was prepared by a "salting out" procedure and polymerase chain reaction (PCR) suitability of the samples was assessed by amplification of a human 
-globin gene region. One microgram of each DNA sample was tested for the presence of HHV-8 DNA sequences by nested PCR amplification.7 HHV-8 PCR was performed on 1 to 4 serial samples per transplant patient, of whom at least one was drawn at the time when CMV and/or HSV-1 reactivation was demonstrated. Reconstruction experiments with titrated cloned HHV-8 templates showed that the nested amplification procedure used was able to detect five copies of target DNA sequence. However, HHV-8 DNA was found neither in the blood donors nor in the transplant patients, including those with concomitant reactivation of CMV and/or HSV-1.
Our failure to detect HHV-8 DNA sequences in buffy-coat cells from the healthy blood donors and the transplant patients examined does not support that HHV-8 is a common infectious agent typically reactivating in the course of immunosuppression. Actually, CD19+ B cells are a target for HHV-8 infection in KS patients.1 Although the lymphoid system has been suggested to represent a possible reservoir of HHV-8-infected cells4 it is not presently known whether B cells are also a site of viral latency. Most human herpesviruses are in fact ubiquitous and lymphotropic. In particular, Epstein-Barr virus (EBV) shares nucleotide sequence homology with HHV-8 and is well known to establish a latent infection in B cells and to be a relevant cofactor in different lymphomas. Nevertheless, EBV genome is hardly detectable in the blood of the vast majority of healthy subjects even when sensitive PCR methods are used.7 Thus, a low HHV-8 load could similarly not be detected during latent infection. However, it is worth considering that HHV-8 genome has been demonstrated in endothelial and spindle cells present in KS lesions9 and in sensory ganglia from KS-positive patients,10 raising the possibility that HHV-8 establishes a latent infection in tissues other than lymphocytes. The high prevalence of HHV-8 in semen from healthy subjects recently reported3 merits further investigation in light of this hypothesis. In conclusion, we consider that data presently available are not at all sufficient to claim that HHV-8 is as ubiquitous as other human herpesviruses. Accordingly, KS typically develops in homosexual males, and the rare occurrences of KS in women appear to be related to sexual contacts with bisexual males. In addition, HHV-8 DNA has been detected at high frequency in human immunodeficiency virus-infected homosexual males with and without KS.2,8 It is also worth reminding that another human herpesvirus, HSV-2, is an almost exclusively sexually transmitted agent. Thus, it may be reasonably conceived that transmission of HHV-8 infection requires specific sexual practices and that development of HHV-8-related diseases is critically favored by underlying immunosuppression.
Angelo De Milito
Giulietta Venturi
Marinunzia Catucci
Laura Romano
Maria Letizia Bianchi Bandinelli
Maurizio Zazzi
Sezione di Microbiologia Dipartimento di Biologia Molecolare Università di Siena Siena, Italy
| |
ACKNOWLEDGMENT |
We acknowledge grant support from IX Progetto AIDS, Istituto Superiore di Sanità, Ministero della Sanità (9402-15), Rome, Italy.
| |
REFERENCES |
1.
Ambroziak JA,
Blackbourn DJ,
Herndier BG,
Glogan RG,
Gullet JH,
McDonald AR,
Lennette ET,
Levy JA:
Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients.
Science
268:582,
1995[Free Full Text]
2.
Nador RG,
Cesarman E,
Chadburn Dawson DB,
Ansari MQ,
Sald J,
Knowles DM:
Primary effusion lymphoma: A distinct clinicopathologic entity associated with Kaposi's sarcoma-associated herpes virus.
Blood
88:645,
1996[Abstract/Free Full Text]
3.
Monini P,
de Lellis L,
Fabris M,
Rigolin F,
Cassai E:
Kaposi's-sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen.
N Engl J Med
334:1168,
1996[Abstract/Free Full Text]
4.
Bigoni B,
Dolcetti R,
de Lellis L,
Carbone A,
Boiocchi M,
Cassai E,
Di Luca D:
Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS.
J Infect Dis
173:542,
1996[Medline]
[Order article via Infotrieve]
5.
Rady PL,
Yen A,
Rollefson JL,
Orengo I,
Bruce S,
Hughes TK,
Tyring SK:
Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients.
Lancet
345:1339,
1995[Medline]
[Order article via Infotrieve]
6.
Boshoff C,
Talbot S,
Kennedy M,
O'Leary J,
Schulz T,
Chang Y:
HHV8 and skin cancers in immunosuppressed patients.
Lancet
347:338,
1996[Medline]
[Order article via Infotrieve]
7.
Whitby D,
Howard MR,
Flowers MT,
Brink NS,
Copas A,
Boshoff C,
Hatzioannou T,
Suggett FEA,
Aldam DM,
Denton AS,
Miller RF,
Weller IVD,
Weiss RA,
Tedder RS,
Schulz TF:
Detection of Kaposi's-sarcoma-associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.
Lancet
346:799,
1995[Medline]
[Order article via Infotrieve]
8.
De Milito A,
Catucci M,
Venturi G,
Romano L,
Almi P,
Valensin PE,
Zazzi M:
Human immunodeficiency virus-1 infection, homosexuality, and Kaposi-associated herpes-like DNA in peripheral blood mononuclear cells.
Blood
87:3521,
1996[Free Full Text]
9.
Boshoff C,
Schulz TF,
Kennedy MM,
Graham AK,
Fisher C,
Thomas A,
McGee JO,
Weiss RA,
O'Leary JJ:
Kaposi's-sarcoma-associated herpesvirus infects endothelial and spindle cells.
Nat Med
1:1274,
1995[Medline]
[Order article via Infotrieve]
10.
Corbellino M,
Parravicini C,
Aubin JT,
Berti E:
Kaposi's-sarcoma and herpesvirus-like DNA sequences in sensory ganglia.
N Engl J Med
334:1341,
1996[Free Full Text]
